You are viewing the site in preview mode

Skip to main content

Advertisement

Table 3 Total lifetime cost, life years, and QALYs for PAH patients in FC II and FC III receiving sildenafil and beraprost

From: Economic evaluation of sildenafil for the treatment of pulmonary arterial hypertension in Indonesia

  FC II FC III
beraprost sildenafil   beraprost sildenafil
Total lifetime cost (USD) 35,863 37,632 30,807 35,059
Life Years
 No discount 26.75 27.91 23.03 25.99
 Discount 16.23 16.94 14.10 15.80
QALYs
 No discount 19.66 20.56 16.64 19.09
 Discount 11.90 12.47 10.08 11.58